1. Alpers DH, Sabesin SM: Fatty liver: Biochemical and clinical aspects. In Schiff L, Schiff ER (eds): Diseases of the Liver, 6th ed. Philadelphia, 1987, JB Lippincott Co. pp 949-978.

2. Baker AL, Rosenberg IH: Hepatic complications of total parenteral nutrition. Am J Med 82: 489-497, 1987.

3. Braillon A, Capron JP, Hervé MA, et al: Liver in obesity. Gut 26: 133-139, 1985.

4. Brawer MK, Austin GE, Lewin KJ: Focal fatty change of the liver, a hitherto poorly recognized entity. Gastroenterology 78: 247-252, 1980.

5. Christoffersen P, Brændstrup O, Juhl E, Poulsen H: Lipogranulomas in human liver biopsies with fatty change. A morphological, biochemical and clinical investigation. Acta Pathol Microbiol Scand [A] 79: 150-158, 1971.

6. Christoffersen P, Nielsen K: Histological changes in human liver biopsies from chronic alcoholics. Acta Pathol Microbiol Scand [A] 80: 557-565, 1972.

7. Clain JE, Stephens DH, Charboneau JW: Ultrasonography and computed tomography in focal fatty liver. Report of two cases with special emphasis on changing appearances over time. Gastroenterology 87: 948-952, 1984.

8. Delladetsima JK, Horn T, Poulsen H: Portal tract lipogranulomas in liver biopsies. Liver 7: 9-17, 1987.

9. Dincsoy HP, Weesner RE, MacGee J: Lipogranulomas in non-fatty human livers. A mineral oil induced environmental disease. Am J Clin Pathol 78: 35-41, 1982.

10. Edmondson HA: Pathology of alcoholism. Am J Clin Pathol 74: 725-742, 1980.

11. Ferrell LD: Hepatic granulomas: a morphologic approach to diagnosis. Surgical Pathol 3: 87-106, 1990.

12. Galambos JT, Wills CE: Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 74: 1191-1195, 1978.

13. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH: Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 21: 109-113, 1986.

14. Lieber CS: Alcohol and the liver: Metabolism of ethanol, metabolic effects and pathogenesis of injury. Acta Med Scand suppl 703: 11-55, 1985.

15. Massarrat S, Jordan G, Sahrhage G, et al: Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver. Acta Hepato-gastroenterol 21: 176-186, 1974.

16. Randall B: Fatty liver and sudden death. Hum Pathol 11: 147-153, 1980.

17. Rubin E, Lieber CS: Alcohol-induced hepatic injury in nonalcoholic volunteers. N Engl J Med 278: 869-876, 1968.

18. Schaffner F, Thaler H: Nonalcoholic fatty liver disease. Prog Liver Dis 8: 283-298, 1986.

19. Silverman JF, Pories WJ, Caro JF: Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu 24 (pt 1): 275-302, 1989.

20. Stone BG, Van Thiel DH: Diabetes mellitus and the liver. Semin Liver Dis 5: 8-28, 1985.

21. Van Ness MM, Diehl AM: Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 111: 473-478, 1989.

22. Wanless IR, Geddie WR: Mineral oil lipogranulomata in liver and spleen. A study of 465 autopsies. Arch Pathol Lab Med 109: 283-286, 1985.

23. Webber BL, Freiman I: The liver in kwashiorkor. A clinical and electron microscopical study. Arch Pathol 98: 400-408, 1974.

24. Yoshikawa J, Matsui O, Takashima T, et al: Focal fatty change of the liver adjacent to the falciform ligament: CT and sonographic findings in five surgically confirmed cases. AJR 149: 491-494, 1987.

25. Bentz MS, Cohen C: Periportal necrosis in Reye's syndrome. One case in a review of eight patients. Am J Gastroenterol 73: 49-53, 1980.

26. Bernuau J, Degott C, Nouel O, et al: Non-fatal acute fatty liver of pregnancy. Gut 24: 340-344, 1983.

27. Bonnell HJ, Beckwith JB: Fatty liver in sudden childhood death. Implications for Reye's syndrome? Am J Dis Child 140: 30-33, 1986.

28. Bove KE, McAdams AJ, Partin JC, et al: The hepatic lesion in Reye's syndrome. Gastroenterology 69: 685-697, 1975.

29. Brown RE, Ishak KG: Hepatic zonal degeneration and necrosis in Reye syndrome. Arch Pathol Lab Med 100: 123-126, 1976.

30. Burroughs AK, Seong NH, Dojcinov DM, et al: Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 51: 481-497, 1982.

31. Campillo B, Bernuau J, Witz M-O, et al: Ultrasonography in acute fatty liver of pregnancy. Ann Intern Med 105: 383-384, 1986.

32. Centers for Disease Control: Reye syndrome -- United States, 1985. MMWR 35: 66-74, 1986.

33. Centers for Disease Control: Reye syndrome surveillance -- United States, 1987 and 1988. MMWR 38: 325-327, 1989.

34. Chang CH, Uchwat F, Masalskis F, Arcinue EL: Morphologic grading of hepatic mitochondrial alteration in Reye's syndrome: Potential prognostic implications. Pediatr Pathol 4: 265-275, 1985.

35. Corkey BE, Hale DE, Glennon MC, et al: Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome. J Clin Invest 82: 782-788, 1988.

36. Crocker JF: Reye's syndrome. Semin Liver Dis 2: 340-352, 1982.

37. Daugherty CC, Gartside PS, Heubi JE, et al: A morphometric study of Reye's syndrome. Correlation of reduced mitochondrial numbers and increased mitochondrial size with clinical manifestations. Am J Pathol 129: 313-326, 1987.

38. Dincsoy HP, Rolfes DB, McGraw CA, Schubert WK: Cholesterol ester storage disease and mesenteric lipodystrophy. Am J Clin Pathol 81: 263-269, 1984.

39. Dodge PR, Brown SB, Ector WL, et al: Consensus conference. The diagnosis and treatment of Reye's syndrome. JAMA 246: 2441-2444, 1981.

40. Duma RJ, Dowling EA, Alexander HC, et al: Acute fatty liver of pregnancy. Report of a surviving patient studied with serial liver biopsies. Ann Intern Med 63: 851-858, 1965.

41. Eisele JW, Barker EA, Smuckler EA: Lipid content in the liver of fatty metamorphosis of pregnancy. Am J Pathol 81: 545-560, 1975.

42. Gauthier M, Guay J, Lacroix J, Lortie A: Reye's syndrome. A reapprasial of diagnosis in 49 presumptive cases. AJDC 143: 1181-1185, 1989.

43. Greene CL, Blitzer MG, Shapira E: Inborn errors of metabolism and Reye syndrome: Differential diagnosis. J Pediatr 113: 156-159, 1988.

44. Heubi JE, Partin JC, Partin JS, Schubert WK: Reye's syndrome: Current concepts. Hepatology 7: 155-164, 1987.

45. Holtzhauer FJ, Campbell RJ, Hall LJ, Halpin TJ: Reye's syndrome. An epidemiologic analysis of mild disease. Am J Dis Child 140: 1231-1236, 1986.

46. Hurwitz ES, Barrett MJ, Bregman D, et al: Public Health Service study of Reye's syndrome and medications: Report of the main study. JAMA 257: 1905-1911, 1987.

47. Ishak KG, Rogers WA: Cryptogenic acute cholangitis -- Association with toxic shock syndrome. Am J Clin Pathol 76: 619-626, 1981.

48. Latham PS, LaBrecque DR, McReynolds JW, Klatskin G: Liver ultrastructure in mitochondrial urea cycle enzyme deficiencies and comparison with Reye's syndrome. Hepatology 4: 404-407, 1984.

49. Lefkowitch JH, Goldstein H, Yatto R, Gerber MA: Cytopathic liver injury in acute delta virus infection. Gastroenterology 92: 1262-1266, 1987.

50. Lichtenstein PK, Heubi JE, Daugherty CC, et al: Grade I Reye's syndrome. A frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection. N Engl J Med 309: 133-139, 1983.

51. Meythaler JM, Varma RR: Reye's syndrome in adults. Diagnostic considerations. Arch Intern Med 147: 61-64, 1987.

52. Minakami H, Oka N, Sato T, et al: Preeclampsia: A microvesicular fat disease of the liver? Am J Obstet Gynecol 159: 1043-1047, 1988.

53. Minuk GY, Lui RC, Kelly JK: Rupture of the liver associated with acute fatty liver of pregnancy. Am J Gastroenterol 82: 457-460, 1987.

54. Montull S, Parés, Bruguera M, et al: Alcoholic foamy degeneration in Spain. Prevalence and clinico-pathological features. Liver 9: 79-85, 1989.

55. Morgan MY, Sherlock S, Scheuer PJ: Acute cholestasis, hepatic failure, and fatty liver in the alcoholic. Scand J Gastroenterol 13: 299-303, 1978.

56. Partin JC, Schubert WK, Partin JS: Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). N Engl J Med 285: 1339-1343, 1971.

57. Peters RL, Edmondson HA, Mikkelsen WP, et al: Tetracycline-induced fatty liver in non-pregnant patients. Am J Surg 113: 622-632, 1967.

58. Phillips MJ, Poucell S, Patterson J, Valencia P: Miscellaneous hepatic conditions. In The Liver: An Atlas and Text of Ultrastructural Pathology. New York, 1987, Raven Press. pp 519-520.

59. Pockros PJ, Peters RL, Reynolds TB: Idiopathic fatty liver of pregnancy: Findings in ten cases. Medicine 63: 1-11, 1984.

60. Remington PL, Rowley D, McGee H, et al: Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics 77: 93-98, 1986.

61. Riely CA: Acute fatty liver of pregnancy. Semin Liver Dis 7: 47-54, 1987.

62. Riely CA, Latham PS, Romero R, Duffy TP: Acute fatty liver of pregnancy. A reassessment based on observations in nine patients. Ann Intern Med 106: 703-706, 1987.

63. Rolfes DB, Ishak KG: Acute fatty liver of pregnancy: A clinicopathologic study of 35 cases. Hepatology 5: 1149-1158, 1985.

64. Rolfes DB, Ishak KG: Liver disease in pregnancy. Histopathology 10: 555-570, 1986.

65. Rowe PC, Valle D, Brusilow SW: Inborn errors of metabolism in children referred with Reye's syndrome. A changing pattern. JAMA 260: 3167-3170, 1988.

66. Rubel LR, Ishak KG: The liver in fatal exertional heatstroke. Liver 3: 249-260, 1983.

67. Sherlock S: Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut 24: 265-269, 1983.

68. Starko KM, Mullick FG: Hepatic and cerebral pathology findings in children with fatal salicylate intoxication: Further evidence for a causal relation between salicylate and Reye's syndrome. Lancet 1: 326-329, 1983.

69. Tanaka K, Kean EA, Johnson B: Jamaican vomiting disease. Biochemical investigation of two cases. N Engl J Med 295: 461-467, 1976.

70. Treem WR, Witzleben CA, Piccoli DA, et al: Medium-chain and long-chain acyl CoA dehydrogenase deficiency: Clinical, pathologic and ultrastructural differentiation from Reye's syndrome. Hepatology 6: 1270-1278, 1986.

71. Uchida T, Kao H, Quispe-Sjogren M, Peters RL: Alcoholic foamy degeneration -- A pattern of acute alcoholic injury of the liver. Gastroenterology 84: 683-692, 1983.

72. Van Coster RN, De Vivo DC, Blake D, et al: Adult Reye's syndrome: A review with new evidence for a generalized defect in intramitochondrial enzyme processing. Neurology 41: 1815-1821, 1991.

73. Zimmerman HJ, Ishak KG: Valproate induced hepatic injury. Analysis of 23 fatal cases. Hepatology 2: 591-597, 1982.

74. Adelasco L, Monarca A, Dantes M, et al: Features of chronic hepatitis in alcoholics. A survey in Milan. Liver 7: 283-289, 1987.

75. Alexander JF, Lischner MW, Galambos JT: Natural history of alcoholic hepatitis. II. The long-term prognosis. Am J Gastroenterol 56: 515-525, 1971.

76. Amano K, Tsukada K, Takeuchi T, et al: IgA deposition in alcoholic liver disease. An immunoelectron microscopic study. Am J Clin Pathol 89: 728-734, 1988.

77. Baptista A, Bianchi L, de Groote J, et al: Alcoholic liver disease: Morphologic manifestations. Lancet 1: 707-711, 1981.

78. Barbatis C, Morton J, Woods JC, et al: Disorganisation of intermediate filament structure in alcoholic and other liver diseases. Gut 27: 765-770, 1986.

79. Blendis LM, Orrego H, Crossley IR, et al: The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease. Hepatology 2: 539-546, 1982.

80. Boitnott JK, Maddrey WC: Alcoholic liver disease: I. Interrelationships among histologic features and the histologic effects of prednisolone therapy. Hepatology 1: 599-612, 1981.

81. Bruguera M, Bertran A, Bombi JA, Rodés J: Giant mitochondria in hepatocytes. A diagnostic hint for alcoholic liver disease. Gastroenterology 73: 1383-1387, 1977.

82. Brunt PW, Kew MC, Scheuer PJ, Sherlock S: Studies in alcoholic liver disease in Britain. 1. Clinical and pathological patterns related to natural history. Gut 15: 52-58, 1974.

83. Burt AD, MacSween RNM: Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 39: 63-67, 1986.

84. Caulet S, Fabre M, Schoevaert D, et al: Quantitative study of centrolobular hepatic fibrosis in alcoholic disease before cirrhosis. Virchows Arch [A] 416: 11-17, 1989.

85. Chedid A, Mendenhall CL, Gartside P, et al: Prognostic factors in alcoholic liver disease. Am J Gastroenterol 86: 210-216, 1991.

86. Chedid A, Mendenhall CL, Tosch T, et al: Significance of megamitochondria in alcoholic liver disease. Gastroenterology 90: 1858-1864, 1986.

87. Cohen JA, Kaplan MM: The SGOT/SGPT ratio -- An indicator of alcoholic liver disease. Dig Dis Sci 24: 835-838, 1979.

88. Crapper RM, Bhathal PS, Mackay IR: Chronic active hepatitis in alcoholic patients. Liver 3: 327-337, 1983.

89. Derr RF, Porta EA, Larkin EC, Rao GA: Is ethanol per se hepatotoxic? J Hepatol 10: 381-386, 1990.

90. Desmet VJ: Alcoholic liver disease. Histological features and evolution. Acta Med Scand suppl 703: 111-126, 1985.

91. Diehl AM: Alcohol-related trafficking accidents. Hepatology 15: 964-966, 1992.

92. Edmondson HA, Peters RL, Frankel HH, Borowsky S: The early stage of liver injury in the alcoholic. Medicine 46: 119-129, 1967.

93. Edmondson HA, Peters RL, Reynolds TB, Kuzma OT: Sclerosing hyaline necrosis of the liver in the chronic alcoholic. A recognizable clinical syndrome. Ann Intern Med 59: 646-673, 1963.

94. Fallon HJ: Alcohol and the terminal hepatic venule: Early lesion or late residual? Gastroenterology 83: 930-932, 1982.

95. Fletcher LM, Kwoh-Gain I, Powell EE, et al: Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: An aid to diagnosis. Hepatology 13: 455-459, 1991.

96. French SW: Nature, pathogenesis and significance of the Mallory body. Sem Liver Dis 1: 217-231, 1981.

97. French SW, Okanoue T, Swierenga SHH, Marceau N: The cytoskeleton of hepatocytes in health and disease. In Farber E, Phillips MJ, Kaufman N (eds): Pathogenesis of Liver Diseases. IAP monograph no. 28. Baltimore, 1987, Williams & Wilkins. pp. 95-112.

98. Galambos JT: Natural history of alcoholic hepatitis. III. Histological changes. Gastroenterology 63: 1026-1035, 1972.

99. Gerber MA, Orr W, Denk H, et al: Hepatocellular hyalin in cholestasis and cirrhosis: Its diagnostic significance. Gastroenterology 64: 89-98, 1973.

100. Gerber MA, Popper H: Relation between central canals and portal tracts in alcoholic hepatitis. A contribution to the pathogenesis of cirrhosis in alcoholics. Hum Pathol 3: 199-207, 1972.

101. Geubel AP, De Galocsy C, Alves N, et al: Liver damage caused by therapeutic vitamin A administration: Estimate of dose-related toxicity in 41 cases. Gastroenterology 100: 1701-1709, 1991.

102. Gluud C, Christoffersen P, Eriksen J, et al: Influence of ethanol on development of hyperplastic nodules in alcoholic men with micronodular cirrhosis. Gastroenterology 93: 256-260, 1987.

103. Goldberg SJ, Mendenhall CL, Connell AM, Chedid A: "Nonalcoholic" chronic hepatitis in the alcoholic. Gastroenterology 72: 598-604, 1977.

104. Goldin RD, Cattle S, Boylston AW: IgA deposition in alcoholic liver disease. J Clin Pathol 39: 1181-1185, 1986.

105. Goodman ZD, Ishak KG: Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 83: 786-796, 1982.

106. Hahn E, Wick G, Pencev D, Timpl R: Distribution of basement membrane proteins in normal and fibrotic human liver liver: Collagen type IV, laminin and fibronectin. Gut 21: 63-71, 1980.

107. Hazan R, Denk H, Franke WW, et al: Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest 54: 543-553, 1986.

108. Hislop WS, Bouchier IA, Allan JG, et al: Alcoholic liver disease in Scotland and northeastern England: Presenting features in 510 patients. Q J Med 52: 232-243, 1983.

109. Horn T, Junge J, Christoffersen P: Early alcoholic liver injury: changes of the Disse space in acinar zone 3. Liver 5: 301-310, 1985.

110. Horn T, Junge J, Christoffersen P: Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J Hepatol 3: 333-340, 1986.

111. Irving MG, Halliday JW, Powell LW: Association between alcoholism and increased hepatic iron stores. Alcohol Clin Exp Res 12: 7-13, 1988.

112. Ishak KG, Zimmerman HJ, Ray MB: Alcoholic liver disease: Pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 15: 45-66, 1991.

113. Jakobovits AW, Morgan MY, Sherlock M: Hepatic siderosis in alcoholics. Dig Dis Sci 24: 305-310, 1979.

114. Johnson RD, Williams R: Genetic and environmental factors in the individual susceptibility to the development of alcoholic liver disease. Alcohol Alcohol 20: 137-616, 1985.

115. Joshi VV: Indian childhood cirrhosis. Perspect Pediatr Pathol 11: 175-192, 1987.

116. Junge J, Horn T, Christoffersen P: Megamitochondria as a diagnostic marker for alcohol induced centrilobular and periportal fibrosis. Virchows Arch [A] 410: 553-558, 1987.

117. Kater L, Jöbsis AC, Baart de la Faille-Kuyper EH, et al: Alcoholic hepatic disease. Specificity of IgA deposits in liver. Am J Clin Pathol 71: 51-57, 1979.

118. Katsuma Y, Swierenga SHH, Khettry U, et al: Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Hepatology 7: 1215-1223, 1987.

119. Khoruts A, Stahnke L, McClain CJ, et al: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13: 267-276, 1991.

120. Lelbach WK: Epidemiology of alcoholic liver disease. Prog Liver Dis 5: 494-515, 1976.

121. LeSage GD, Baldus WP, Fairbanks VF, et al: Hemochromatosis: Genetic or alcohol-induced? Gastroenterology 84: 1471-1477, 1983.

122. Levin DM, Baker AL, Riddell RH, et al: Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 66: 429-434, 1979.

123. Lieber CS: Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 319: 1639-1650, 1988.

124. Lieber CS, Garro A, Leo MA, et al: Alcohol and cancer. Hepatology 6: 1005-1019, 1986.

125. Lischner MW, Alexander JF, Galambos JT: Natural history of alcoholic hepatitis. I. The acute disease. Am J Dig Dis 16: 481-494, 1971.

126. MacSween RN, Burt AD: Histologic spectrum of alcoholic liver disease. Semin Liver Dis 6: 221-232, 1986.

127. Maddrey WC: Alcoholic hepatitis: Clinicopathologic features and therapy. Semin Liver Dis 8: 91-102, 1988.

128. Maher JJ: Hepatic fibrosis caused by alcohol. Sem Liver Dis 10: 66-74, 1990.

129. Marbet UA, Bianchi L, Meury U, Stalder GA: Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 4: 364-372, 1987.

130. Mendenhall CL and the VA Cooperative Study Group on Alcoholic Hepatitis: Alcoholic hepatitis. Clin Gastroenterol 10: 417-441, 1981.

131. Mendenhall CL, Seeff L, Diehl AM, et al: Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology 14: 581-589, 1991.

132. Mezey E: Interaction between alcohol and nutrition in the pathogenesis of alcoholic liver disease. Semin Liver Dis 11: 340-348, 1991.

133. Minato Y, Hasumura Y, Takeuchi J: The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease. Hepatology 3: 559-566, 1983.

134. Morgan MY, Sherlock S, Scheuer PJ: Portal fibrosis in the livers of alcoholic patients. Gut 19: 1015-1021, 1978.

135. Naccarato R, Farinati F: Hepatocellular carcinoma, alcohol, and cirrhosis: Facts and hypotheses. Dig Dis Sci 36: 1137-1142, 1991.

136. Nagore N, Scheuer PJ: Does a linear pattern of sinusoidal IgA deposition distinguish between alcoholic and diabetic liver disease? Liver 8: 281-286, 1988.

137. Nakano M, Worner TM, Lieber CS: Perivenular fibrosis in alcoholic liver injury: Ultrastructure and histologic progression. Gastroenterology 83: 777-785, 1982.

138. Nasrallah SM, Nassar VH, Galambos JT: Importance of terminal hepatic venule thickening. Arch Pathol Lab Med 104: 84-86, 1980.

139. Nei J, Matsuda Y, Takada A: Chronic hepatitis induced by alcohol. Dig Dis Sci 28: 207-215, 1983.

140. Nyfors A, Poulsen H: Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis. Am J Surg Pathol 1: 235-243, 1977.

141. Ohta M, Marceau N, Perry G, et al: Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 59: 848-856, 1988.

142. Okanoue T, Burbige EJ, French SW: The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med 107: 459-463, 1983.

143. Orrego H, Blake JE, Blendis LM, Medline A: Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 92: 208-214, 1987.

144. Orrego H, Israel Y, Blake JE, Medline A: Assessment of prognostic factors in alcoholic liver disease: Toward a global quantitative expression of severity. Hepatology 3: 896-905, 1983.

145. Orrego H, Israel Y, Blendis LM: Alcoholic liver disease: Information in search of knowledge? Hepatology 1: 267-283, 1981.

146. Parés A, Caballería, Bruguera M, et al: Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatology 2: 33-42, 1986.

147. Perrillo RP, Griffin R, DeSchryver-Kecskemeti K, et al: Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase. A combined clinical and pathological study. Am J Dig Dis 23: 1061-1066, 1978.

148. Phillips MJ: Mallory bodies and the liver. Lab Invest 47: 311-313, 1982.

149. Ray MB: Distribution patterns of cytokeratin antigen determinants in alcoholic and nonalcohlic liver diseases. Hum Pathol 18: 61-66, 1987.

150. Russell RM, Boyer JL, Bagheri SA, Hruban Z: Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites. N Engl J Med 291: 435-440, 1974.

151. Sakai Y, Izumi N, Hasumura Y, Takeuchi J: Chronic hepatitis in alcoholics: Two case with alcoholic liver disease whose liver biosies showed decrease of inflammatory activity after abstinence. Acta Hepatol Jpn 29: 673-678, 1988.

152. Schenker S: Alcoholic liver disease: Evaluation of natural history and prognostic factors. Hepatology 4: 36S-43S, 1984.

153. Schenker S, Perkins HS, Sorrell MF: Should patients with end-stage alcoholic liver disease have a new liver? Hepatology 11: 314-319, 1990.

154. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al: The pathology of hepatitis C. Hepatology 15: 567-571, 1992.

155. Skog OJ: The wetness of drinking cultures: A key variable in epidemiology of alcoholic liver cirrhosis. Acta Med Scand suppl 703: 157-184, 1985.

156. Sørensen TIA: Alcohol and liver injury: dose-related or permissive effect? Liver 9: 189-197, 1989.

157. Sørensen TIA, Orholm M, Bentsen KD, et al: Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2: 241-244, 1984.

158. Stewart RV, Dincsoy HP: The signficance of giant mitochondria in liver biopsies as observed by light microscopy. Am J Clin Pathol 78: 293-298, 1982.

159. Stromeyer FW, Ishak KG: Histology of the liver in Wilson's disease. A study of 34 cases. Am J Clin Pathol 73: 12-24, 1980.

160. Sumithran E, Looi LM: Copper-binding protein in liver cells. Hum Pathol 16: 677-682, 1985.

161. Swerdlow MA, Chowdhury LN: IgA deposition in liver in alcoholic liver disease. An index of progressive injury. Arch Pathol Lab Med 108: 416-419, 1984.

162. Swerdlow MA, Chowdhury LN, Horn T: Patterns of IgA deposition in liver tissues in alcoholic liver diseases. Am J Clin Pathol 77: 259-266, 1982.

163. Takada A, Nei J, Matsuda Y, Kanayama R: Clinicopathological study of alcoholic fibrosis. Am J Gastroenterol 77: 660-666, 1982.

164. Takahashi T, Kamimura T, Ichida H: Ultrastructural findings on polymorphonuclear leucocyte infiltration and acute hepatocellular damage in alcoholic hepatitis. Liver 7: 347-358, 1987.

165. Takase S, Takada N, Enomoto N, et al: Different types of chronic hepatitis in alcoholic patients: Does chronic hepatitis induced by alcohol exist? Hepatology 13: 876-881, 1991.

166. Thiele DL: Tumor necrosis factor, the acute phase response and the pathogenesis of alcoholic liver disease. Hepatology 9: 497-499, 1989.

167. Tsukamoto H, Gaal K, French SW: Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: Status report. Hepatology 12: 599-608, 1990.

168. Uchida T, Kronborg I, Peters RL: Alcoholic hyalin-containing hepatocytes -- a characteristic morphologic appearance. Liver 4: 233-243, 1984.

169. Uchida T, Kronborg I, Peters RL: Giant mitochondria in the alcoholic liver disease -- their identification, frequency, and pathologic signficance. Liver 4: 29-38, 1984.

170. Uchida T, Peters RL: The nature and origin of proliferated bile ductules in alcoholic liver disease. Am J Clin Pathol 79: 326-333, 1983.

171. Uchida T, Shikata T, Govindarajan S, Kronborg I: The characteristics of alcoholic liver disease in Japan. Clinicopathologic comparison with alcoholic liver disease in the United States. Liver 7: 290-297, 1987.

172. van de Wiel A, Delacroix DL, van Hattum J, et al: Characteristics of serum IgA and liver IgA deposits in alcoholic liver disease. Hepatology 7: 95-99, 1987.

173. Van Eyken P, Sciot R, Desmet VJ: A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology 13: 605-617, 1988.

174. Van Waes L, Lieber CS: Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 73: 646-650, 1977.

175. Wands JR, Blum HE: Hepatitis B and C virus and alcohol-induced liver injury. Hepatology 14: 730-733, 1991.

176. Weiner FR, Czaja MJ, Zern MA: Ethanol and the liver. In Arias IM, Jakoby WB, Popper H, et al (eds): The Liver: Biology and Pathobiology, 2nd ed. New York, 1988, Raven Press. pp 1169-1193.

177. Williams ALB, Hoofnagle JH: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relation to cirrhosis. Gastroenterology 95: 734-737, 1988.

178. Worman HJ: Cellular intermediate filament networks and their derangement in alcoholic hepatitis. Alcohol Clin Exp Res 14: 789-804, 1990.

179. Worner TM, Lieber CS: Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254: 627-630, 1985.

180. Yokoo H, Minick OT, Batti F, Kent G: Morphologic variants of alcoholic hyalin. Am J Pathol 69: 25-40, 1972.

181. Yokoo H, Singh SK, Hawasli AH: Giant mitochondria in alcoholic liver disease. Arch Pathol Lab Med 102: 213-214, 1978.

182. Zatloukal K, Denk H, Spurej G, et al: High molecular weight component of Mallory bodies detected by a monoclonal antibody. Lab Invest 62: 427-434, 1990.

183. Zetterman RK, Sorrell MF: Immunologic aspects of alcoholic liver disease. Gastroenterology 81: 616-624, 1981.

184. Andersen T, Gluud C: Liver morphology in morbid obesity: A literature study. Int J Obesity 8: 97-106, 1984.

185. Batman PA, Scheuer PJ: Diabetic hepatitis preceding the onset of glucose intolerance. Histopathology 9: 237-243, 1985.

186. Capron JP, Delamarre J, Dupas JL, et al: Fasting in obesity. Another cause of liver injury with alcoholic hyaline? Dig Dis Sci 27: 265-268, 1982.

187. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H: Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 79: 131-137, 1980.

188. Cuellar RE, Tarter R, Hays A, Van Thiel DH: The possible occurrence of "alcoholic hepatitis" in a patient with bulimia in the absence of diagnosable alcoholism. Hepatology 7: 878-883, 1987.

189. Diehl AM, Goodman Z, Ishak KG: Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95: 1056-1062, 1988.

190. Falchuk KR, Fiske SC, Haggitt RC, et al: Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 78: 535, 541, 1980.

191. Fouin-Fortunet H, LeQuernec L, Erlinger S, et al: Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: A possible consequence of lithocholate toxicity. Gastroenterology 82: 932-937, 1982.

192. Haines NW, Baker AL, Boyer JL, et al: Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: A prospective study. Hepatology 1: 161-167, 1981.

193. Hamilton DL, Vest TK, Brown BS, et al: Liver injury with alcoholiclike hyalin after gastroplasty for morbid obesity. Gastroenterology 85: 722-726, 1983.

194. Hay JE, Czaja AJ, Rakela J, Ludwig J: The nature of unexplained chronic aminotransferase elevations of mild to moderate degree in asymptomatic patients. Hepatology 9: 193-197, 1989.

195. Itoh S, Igarashi M, Tsukada Y, Ichinoe A: Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy. Acta Hepatogastroenterol 24: 415-418, 1977.

196. Itoh S, Yougel T, Kawagoe K: Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82: 650-654, 1987.

197. Kimura H, Kako M, Yo K, Oda T: Alcoholic hyalins (Mallory bodies) in a case of Weber-Christian disease: Electron microscopic observations of liver involvement. Gastroenterology 78: 807-812, 1980.

198. Klain J, Fraser D, Goldstein J, et al: Liver histology abnormalities in the morbidly obese. Hepatology 10: 873-876, 1989.

199. Lee RG: Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol 20: 594-598, 1989.

200. Lewis JH, Mullick F, Ishak KG, et al: Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol 21: 59-67, 1990.

201. Lewis JH, Ranard RC, Caruso A, et al: Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients. Hepatology 9: 679-685, 1989.

202. Ludwig J, Viggiano TR, McGill DB, Ott BJ: Nonalcoholic steatohepatitis. Mayo Clinic Experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438, 1980.

203. Marubbio AT Jr, Buchwald H, Schwartz MZ, Varco R: Hepatic lesions of central pericellular fibrosis in morbid obesity, and after jejunoileal bypass. Am J Clin Pathol 66: 684-691, 1976.

204. Moran JR, Ghishan FK, Halter SA, Greene HL: Steatohepatitis in obese children: A cause of chronic liver dysfunction. Am J Gastroenterol 78: 374-377, 1983.

205. Nagore N, Scheuer PJ: The pathology of diabetic hepatitis. J Pathol 156: 155-160, 1988.

206. Nasrallah SM, Wills CE Jr, Galambos JT: Hepatic morphology in obesity. Dig Dis Sci 26: 325-327, 1981.

207. Pessayre D, Bichara M, Feldmann G, et al: Perhexiline maleate-induced cirrhosis. Gastroenterology 76: 170-177, 1979.

208. Peters RL, Gay T, Reynolds TB: Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Clin Pathol 63: 318-331, 1975.

209. Peura DA, Stromeyer FW, Johnson LF: Liver injury with alcoholic hyaline after intestinal resection. Gastroenterology 79: 128-130, 1980.

210. Powell EE, Cooksley WGE, Hanson R, et al: The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74-80, 1990.

211. Powell EE, Searle J, Mortimer R: Steatohepatitis associated with limb lipodystrophy. Gastroenterology 97: 1022-1024, 1989.

212. Seki K, Minami Y, Nishikawa M, et al: "Nonalcoholic steatohepatitis" induced by massive doses of synthetic estrogen. Gastroenterol Jpn 18: 197-203, 1983.

213. Simon JB, Manley PN, Brien JF, Armstrong PW: Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med 311: 167-172, 1984.

214. Vyberg M, Ravn V, Andersen B: Pattern of progression in liver injury following jejunoileal bypass for morbid obesity. Liver 7: 271-276, 1987.

215. Wanless IR, Bargman JM, Oreopoulos DG, Vas SI: Subcapsular steatonecrosis in response to peritoneal insulin delivery: A clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 2: 69-74, 1989.

216. Wanless IR, Lentz JS: Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 12: 1106-1110, 1990.